Trademark Overview

---

On Thursday, June 21, 2001, a trademark application was filed for ELEVARDA with the United States Patent and Trademark Office. The USPTO has given the ELEVARDA trademark a serial number of 76276097. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 28, 2012. This trademark is owned by AstraZeneca AB. The ELEVARDA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of inflammatory conditions

General Information

---

Serial Number	76276097
Word Mark	ELEVARDA
Filing Date	Thursday, June 21, 2001
Status	710 - CANCELLED - SECTION 8
Status Date	Friday, September 28, 2012
Registration Number	3059772
Registration Date	Tuesday, February 21, 2006
Mark Drawing	1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition Date	Tuesday, November 29, 2005

Trademark Statements

---

Goods and Services

Pharmaceutical preparations for the treatment of inflammatory conditions

Classification Information

---

International Class	005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes	006, 018, 044, 046, 051, 052
Class Status Code	2 - Sec. 8 - Entire Registration
Class Status Date	Friday, September 28, 2012
Primary Code	005
First Use Anywhere Date	NOT AVAILABLE
First Use In Commerce Date	NOT AVAILABLE

Trademark Owner History

---

Party Name	AstraZeneca AB
Party Type	30 - Original Registrant
Legal Entity Type	16 - Limited Liability Company
Address	S 151 85 Sodertalje SE

---

Party Name	AstraZeneca AB
Party Type	20 - Owner at Publication
Legal Entity Type	16 - Limited Liability Company
Address	S 151 85 Sodertalje SE

---

Party Name	AstraZeneca AB
Party Type	10 - Original Applicant
Legal Entity Type	16 - Limited Liability Company
Address	S 151 85 Sodertalje SE

Trademark Events

---

Event Date	Event Description
Friday, September 28, 2012	CANCELLED SEC. 8 (6-YR)
Monday, July 23, 2007	ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 23, 2007	TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 18, 2006	REVIEW OF CORRESPONDENCE COMPLETE
Monday, March 27, 2006	PAPER RECEIVED
Wednesday, March 22, 2006	UNDELIVERABLE MAIL - COURTESY COPY MAILED
Tuesday, March 14, 2006	PAPER RECEIVED
Tuesday, February 21, 2006	REGISTERED-PRINCIPAL REGISTER
Friday, December 2, 2005	UNDELIVERABLE MAIL - NO ACTION TAKEN
Monday, November 21, 2005	PAPER RECEIVED
Tuesday, November 29, 2005	PUBLISHED FOR OPPOSITION
Wednesday, November 9, 2005	NOTICE OF PUBLICATION
Wednesday, October 19, 2005	AMENDMENT/PETITION AFTER APPROVAL FOR PUB ENTERED
Wednesday, July 20, 2005	1(B) BASIS DELETED; NEW BASIS REQUESTED
Tuesday, February 15, 2005	NOTICE OF ALLOWANCE CANCELLED
Wednesday, July 20, 2005	PETITION TO DIRECTOR - GRANTED
Tuesday, February 15, 2005	PETITION TO DIRECTOR RECEIVED
Tuesday, February 15, 2005	PAPER RECEIVED
Friday, August 27, 2004	EXTENSION 2 GRANTED
Thursday, August 19, 2004	EXTENSION 2 FILED
Thursday, August 19, 2004	TEAS EXTENSION RECEIVED
Friday, August 13, 2004	CASE FILE IN TICRS
Saturday, March 27, 2004	TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 18, 2004	EXTENSION 1 GRANTED
Wednesday, February 18, 2004	EXTENSION 1 FILED
Wednesday, February 18, 2004	TEAS EXTENSION RECEIVED
Tuesday, August 19, 2003	NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 27, 2003	PUBLISHED FOR OPPOSITION
Wednesday, May 7, 2003	NOTICE OF PUBLICATION
Monday, December 9, 2002	SEC. 44(D) CLAIM DELETED
Tuesday, January 7, 2003	APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 9, 2002	CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 9, 2002	PAPER RECEIVED
Wednesday, October 30, 2002	INQUIRY AS TO SUSPENSION MAILED
Tuesday, October 16, 2001	UNRESPONSIVE/DUPLICATE PAPER RECEIVED
Wednesday, August 29, 2001	LETTER OF SUSPENSION MAILED
Wednesday, August 22, 2001	ASSIGNED TO EXAMINER

Related Keywords

---

elevarda conditions inflammatory treatment preparations pharmaceutical